Professor Peter Sandercock

Emeritus Professor of Medical Neurology


Studied Medicine at the University of Oxford, and undertook my postgraduate clinical training in Stoke-on-Trent, Manchester, Oxford and Liverpool, followed by a visiting academic fellowship at McMaster University Canada. My initial research was on the epidemiology of stroke in Oxfordshire, and in clinical trials of stroke prevention.

I set up and ran the first International Stroke Trial (IST-1), the first ‘mega-trial’ in acute ischaemic stroke from 1991-1997.19,453 patients were recruited within 48 hours of stroke onset from 467 hospitals in 37 countries. I am the Co-Chief Investigator of IST-3, the largest-ever trial of ‘clot-busting’ thrombolytic therapy for acute ischaemic stroke with 3035 patients. 

My main academic activities are teaching, preparing educational maetrials on stroke for the World Stroke Organisation and contribting to clinical trial research governance though membership or Chairmanship of Trial Steering Committes and Trial data Monitoring Committees.



Responsibilities & affiliations

Member of the Board of Directors World Stroke Organisation.  Commissioning Editor for the World Stroke Academy.  

View all 233 publications on Research Explorer